KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Payables: 2009-2025

Historic Payables for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to $15.2 million.

  • Novavax's Payables fell 73.53% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.6 million, marking a year-over-year decrease of 56.82%. This contributed to the annual value of $41.6 million for FY2024, which is 68.65% down from last year.
  • Novavax's Payables amounted to $15.2 million in Q3 2025, which was down 69.90% from $50.6 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Payables ranged from a high of $710.7 million in Q2 2022 and a low of $15.2 million during Q3 2025.
  • Over the past 3 years, Novavax's median Payables value was $57.7 million (recorded in 2024), while the average stood at $71.2 million.
  • Per our database at Business Quant, Novavax's Payables spiked by 4,411.72% in 2021 and then crashed by 87.72% in 2023.
  • Quarterly analysis of 5 years shows Novavax's Payables stood at $127.0 million in 2021, then surged by 326.13% to $541.4 million in 2022, then plummeted by 75.51% to $132.6 million in 2023, then slumped by 68.65% to $41.6 million in 2024, then tumbled by 73.53% to $15.2 million in 2025.
  • Its Payables stands at $15.2 million for Q3 2025, versus $50.6 million for Q2 2025 and $34.2 million for Q1 2025.